# Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension

Study · id `cardio:ct-nct00971165` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00971165](<https://clinicaltrials.gov/study/NCT00971165>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00971165

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 655 participants.

## Technical summary

Registry record NCT00971165. Randomized; quadruple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2014-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 655 participants (enrolled count; ClinicalTrials.gov record NCT00971165, source copy `cardio:ctgov-nct00971165-2015-02-12`, retrieved 2026-10-26)
- Start date: 2010-07 (registry gives no type) (ClinicalTrials.gov record NCT00971165, source copy `cardio:ctgov-nct00971165-2015-02-12`, retrieved 2026-10-26)
- Primary completion: 2014-09 (actual) (ClinicalTrials.gov record NCT00971165, source copy `cardio:ctgov-nct00971165-2015-02-12`, retrieved 2026-10-26)
- Completion: 2014-09 (actual) (ClinicalTrials.gov record NCT00971165, source copy `cardio:ctgov-nct00971165-2015-02-12`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT00971165, source copy `cardio:ctgov-nct00971165-2015-02-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00971165-2015-02-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
- Acronym: PREVER
- Condition: Hypertension
- Condition: Cardiovascular Disease
- Intervention (Drug): losartan
- Intervention (Drug): Chlorthalidone plus amiloride
- Lead sponsor: Hospital de Clinicas de Porto Alegre
- Lead sponsor class: OTHER
- Collaborator: Financiadora de Estudos e Projetos
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Losartan (`cardio:losartan`)
- Registry lists this organization as the lead sponsor: Hospital de Clinicas de Porto Alegre (`cardio:org-hospital-de-clinicas-de-porto-alegre`)
- Registry lists this organization as a collaborator: Financiadora de Estudos e Projetos (`cardio:org-financiadora-de-estudos-e-projetos`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial (`cardio:pubmed-26938814`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial (`cardio:pubmed-33047257`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0a517b945edf743e23b5b3b4eab543fc03bea9ddfd41055843dd4a0f70b5d53d
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
